Samsung Medical Center
| République de Corée | Turquie | Espagne | |
| Chirurgie de correction des déformations osseuses | de $8,200 | de $2,500 | de $15,000 |
| Chimiothérapie pour le cancer du sein | de $19,200 | de $1,200 | de $3,500 |
| Thérapie à l'actinium-225 | - | de $22,955 | de $45,000 |
| Résection osseuse | - | de $8,000 | de $20,000 |
| Radiothérapie pour le cancer colorectal | - | de $7,000 | de $10,000 |
Bookimed ne rajoute pas de frais pour les traitements de Cancer des os. Les tarifs proviennent des listes de prix officielles des cliniques. Vous payez directement à la clinique pour votre traitement à votre arrivée dans le pays.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans le traitement de Cancer des os et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de traitement de Cancer des os.
South Korea provides advanced bone cancer treatments focused on limb preservation and biological reconstruction. Specialized centers utilize heavy ion therapy, robotic surgery, and multidisciplinary tumor boards. These JCI-accredited facilities integrate neoadjuvant chemotherapy with surgical precision to maximize functional outcomes for sarcoma patients.
Bookimed Expert Insight: While many countries offer oncology, South Korea stands out for functional recovery. Clinics like Seoul National University Hospital and Samsung Medical Center serve over 1,500,000 patients annually. This massive volume allows specialists to refine niche reconstruction techniques that general hospitals rarely perform.
Patient Consensus: Patients prioritize finding orthopedic oncologists who specialize in limb-sparing resection rather than amputation. They often seek second opinions at large university hospitals to ensure they achieve the best possible walking ability and long-term rehabilitation.
South Korea reports a 5-year survival rate for localized bone cancer between 60% and 75%. Success rates reach 80% to 90% for low-grade chondrosarcoma. Leading facilities like Seoul National University Hospital employ limb-salvage protocols to preserve function and avoid amputation during tumor removal.
Bookimed Expert Insight: Korea University Anam Hospital specializes in bloodless surgery and robotic techniques for oncology. This focus on precision often leads to faster recovery after complex sarcoma resections. Their expertise in limb-salvage surgery supports high survival while maintaining the patient's quality of life.
Patient Consensus: Patients emphasize finding a specialized team with sarcoma experience is vital. The focus often shifts from simple survival to achieving successful limb salvage and long-term functional mobility.
Top South Korean hospitals for bone cancer treatment include Samsung Medical Center, Seoul National University Hospital, Asan Medical Center, and Severance Hospital. These Joint Commission International (JCI) accredited facilities utilize multidisciplinary musculoskeletal tumor centers. They specialize in complex limb-salvage surgeries and advanced diagnostic imaging.
Bookimed Expert Insight: While many facilities offer orthopedic services, SNUH and Severance Hospital stand out for their century-long history. These institutions pioneered bone cancer care in Korea. Our data shows SNUH serves 10,700 patients daily. This massive volume ensures surgeons maintain high expertise in rare sarcoma variants.
Patient Consensus: Patients note that the best outcomes for rare bone cancers come from specialized sarcoma teams in Seoul. They emphasize seeking hospitals that combine surgery, radiation, and pathology under one roof.